Copyright and Disclaimer Print  



     Alberta Regulation 292/2003

     Marketing of Agricultural Products Act

     ALBERTA MILK PLAN MINIMUM PRICE FOR
     SUB-CLASS 1A MILK ORDER

     Filed:  October 2, 2003

Made by the Alberta Energy and Utilities Board on September 30, 2003
pursuant to section 5(4) of the Alberta Milk Plan Regulation.



1   The minimum price for sub-class 1a milk to be paid by processors for a
hectolitre of sub-class 1a milk is $69.11.



2   The Alberta Milk Plan Minimum Price for Sub-class 1a Milk Order (AR
282/2003) is repealed.



3   This Order comes into force on October 16, 2003.


     ------------------------------

     Alberta Regulation 293/2003

     Cancer Programs Act

     CANCER PROGRAMS AMENDMENT REGULATION

     Filed:  October 7, 2003

Made by the Minister of Health and Wellness (M.O. 97/2003) on October 1,
2003 pursuant to sections 16 and 22 of the Cancer Programs Act.


1   The Cancer Programs Regulation (AR 242/98) is amended by this
Regulation.


2   The Schedule is repealed and the following Schedule is substituted:


     SCHEDULE


Drug
Group
Dosage Form
Criteria


13 Cis-RETINOIC ACID
     2
capsules
Pediatrics
  restricted to the treatment of advanced stage neuroblastoma following
POG/CCG Protocols
  prescribing limited to written authorization by physicians recommended by
the pediatric tumour program


ALL-TRANS RETINOIC ACID
     2
capsules
  restricted to treatment of acute promyelocytic leukemia
  prescribing limited to written authorization by physicians recommended by
the hematology/lymphoma tumour program or the pediatric tumour program


AMSACRINE
     2
injectable



ANAGRELIDE
     1
capsules
  for thrombocytosis due to myeloproliferative disorder
  prescribing limited to written authorization by physicians recommended by
the hematology/lymphoma tumour program


ANASTROZOLE
     1
tablets
  for post-menopausal patients with receptor-positive, metastatic breast
cancer who have progressed or have experienced severe side effects on prior
hormone therapy



     2
tablets
  for adjuvant use in invasive breast cancer patients who are
post-menopausal, hormone receptor positive and are at risk of a
thromboembolic event.  Risk is defined as a personal history of a previous
thromboembolic event either while on tamoxifen or otherwise
  prescribing limited to written authorization by named physicians as
recommended by the breast tumour program


ASPARAGINASE
     3
injectable



BCG
     1
injectable
  bladder carcinoma


BICALUTAMIDE
     1
tablets
  restricted to patients who are intolerant to Nilutamide or Flutamide
  approved dosage is 50 mg daily


BLEOMYCIN
     1
     2
injectable
pump



BUSERELIN
     1
injectable
  prostate cancer
  Restricted to:
Stage II (T2a-T2c): Neoadjuvant use pre RT (2 months pre and during RT).
Neoadjuvant use pre radical prostatectomy (4 months pre)
Stage III (T3a-T4b): Neoadjuvant use pre RT (2 months pre and during RT).
Adjuvant use (3 years post RT)
Stage IV (N1-N3) (M1-M1c): As monotherpy in medical castration.
In total androgen blockade (medical castration and nonsteriodal
antiandrogen)
  Guidelines for LHRH use in the above stated stages include: LHRH agonists
are indicated for use in patients at risk of thromboembolic disease,
strokes (CVA), myocardial infarction and also for consideration in patients
with dyslipidemia, hypertension, diabetes mellitus or where a patient is
considered intolerant to cyproterone acetate or megestrol acetate


BUSULFAN
     1
tablets



CAPECITABINE
     2
oral
 metastatic or advanced breast cancer and previous treatment with an
anthracycline, unless an anthracycline is contraindicated
  prescribing limited to written authorization by physicians recommended by
the breast tumour program



     2
oral
  option in first line treatment of advanced or metastatic colorectal
cancer
  prescribing limited to written authorization by named physicians as
recommended by the GI tumour program


CARBOPLATIN
     1
injectable



CARMUSTINE
     1
injectable, topical



CHLORAMBUCIL
     1
tablets



CISPLATIN
     1
injectable



CLADRIBINE
     2
injectable
  restricted to treatment of hairy cell leukemia
  Waldenstrom's macroglobulinemia
  hematologic malignancies (histocytosis-X, cutaneous T-cell lymphoma,
systemic mast cell disease)
  prescribing limited to written authorization by physicians recommended by
the hematology/lymphoma tumour program



     3
injectable
POG Protocol 9720
prescribing limited to written authorization by physicians recommended by
the pediatric tumour program


CLODRONATE
     1
oral
  treatment of osteolytic bone lesions in metastatic breast cancer


CYCLOPHOSPHAMIDE
     1
injectable, tablets



CYPROTERONE
     1
tablets



CYTARABINE
     1
injectable



CYTARABINE LIPOSOMAL
     2
injectable
  for intrathecal management of neoplastic meningitis due to solid tumours
or lymphoma


DACARBAZINE
     1
injectable



DACTINOMYCIN
     1
injectable



DAUNORUBICIN
     1
injectable



DEXAMETHASONE
     1
injectable, tablets
  antiemetic use NOT covered


DOCETAXEL
     2
injectable
  treatment of metastatic breast cancer after failure of any previous
chemotherapy regimen
  as a single agent or in combination, as an option for first line
treatment of metastatic breast cancer
  only one taxane is to be administered to any one patient
  prescribing limited to written authorization by named physicians as
recommended by the breast tumour program



     2
injectable
Breast Neoadjuvant
  following a neoadjuvant anthracycline containing regimen in locally
advanced (Stage IIIA or IIIB) breast cancer
  prescribing limited to written authorization by named physicians as
recommended by the breast tumour program



     2
injectable
Breast Adjuvant
  (with doxorubicin and cyclophosphamide (TAC)) as an adjuvant treatment of
1-3 node positive breast cancer
  prescribing limited to written authorization by named physicians as
recommended by the breast tumour program



     2
injectable
  2nd line therapy in patients with advanced or metastatic non-small cell
lung cancer with good performance status (ECOG 0-2) and no symptomatic or
uncontrolled brain metastases
  prescribing limited to written authorization by named physicians as
recommended by the lung tumour program


DOXORUBICIN
     1
injectable



DOXORUBICIN LIPOSOMAL
     2
injectable
  Kaposi's sarcoma



     2
injectable
  2nd or 3rd line treatment of ovarian cancer, fallopian tube carcinoma and
primary peritoneal neoplasms
  prescribing limited to written authorization by named physicians as
recommended by the gynecology tumour program


EPIRUBICIN
     2
injectable
Breast Cancer
  adjuvant (node positive) and neoadjuvant (stage II and III) treatment of
pre and post-menopausal breast cancer patients
  prescribing limited to written authorization by named physicians as
recommended by the breast tumour program



     2
injectable
Esophagogastric Cancer
  used (in combination with cisplatin and fluorouracil) in the treatment of
locally advanced or metastatic esophagogastric cancer in patients with good
performance status



     3
injectable
NCIC MA21 Trial
  use as adjuvant treatment in NCIC MA21 Trial
  prescribing limited to written authorization by clinical trial principal
investigator(s) or co-investigators


ERWINIA ASPARAGINASE
     3
injectable
  restricted to use in patients hypersensitive to E. Coli asparaginase for
remission induction in acute lymphoblastic leukemia
  prescribing limited to written authorization by physicians recommended by
the pediatric tumour program or the hematology/ lymphoma program


ESTRAMUSTINE
     1
capsules



ETOPOSIDE
     1
injectable, capsules



EXEMESTANE
     2
oral
  for hormonal treatment of advanced breast cancer in post-menopausal women
who have progressed following hormonal therapy
  prescribing limited to written authorization by named physicians as
recommended by the breast tumour program


FLUDARABINE
     2
injectable, tablets
  previously treated or untreated chronic lymphocytic leukemia
  low grade lymphoma
  Waldenstrom's macroglobulinemia
  prescribing limited to written authorization by physicians recommended by
the hematology tumour program


FLUOROURACIL
     1

     2
injectable, cream
pump



FLUTAMIDE
     1
tablets
  prostate cancer


GEMCITABINE
     2
injectable
Non-small Cell Lung Cancer
  patients who are unable to tolerate vinorelbine or paclitaxel containing
regimens with documented reason for intolerance
  prescribing limited to written authorization by physicians recommended by
the lung tumour program



     2
injectable
Bladder Cancer
  Gemcitabine/Cisplatin as first line chemotherapy in locally
advanced/metastatic bladder cancer
  prescribing limited to written authorization by physicians recommended by
the GU tumour program



     2
injectable
Pancreas
  locally advanced or metastatic adenocarcinoma of the pancreas
  prescribing limited to written authorization by physicians recommended by
the GI tumour program



     2
injectable
Hematology
  Gemcitabine, Dexamethasone, Cisplatin for relapsed or refractory Hodgkins
or Non-Hodgkins Lymphoma (GDP regimen)
  prescribing limited to written authorization by named physicians as
recommended by the hematology/lymphoma program


GOSERELIN
     1
injectable
  prostate cancer
  Restricted to:
Stage II (T2a-T2c): Neoadjuvant use pre RT (2 months pre and during RT).
Neoadjuvant use pre radical prostatectomy (4 months pre)
Stage III (T3a-T4b): Neoadjuvant use pre RT (2 months pre and during RT).
Adjuvant use (3 years post RT)
Stage IV (N1-N3) (M1-M1c): As monotherpy in medical castration
In total androgen blockade (medical castration and nonsteriodal
antiandrogen)
  Guidelines for LHRH use in the above stated stages include: LHRH agonists
are indicated for use in patients at risk of thromboembolic disease,
strokes (CVA), myocardial infarction and also for consideration in patients
with dyslipidemia, hypertension, diabetes mellitus or where a patient is
considered intolerant to cyproterone acetate or megestrol acetate



     2
injectable
  breast cancer. 2nd line hormonal therapy for recurrent or metastatic
disease in either or both estrogen and progesterone receptor positive pre
and perimenopausal patients after tamoxifen failure
  prescribing limited to written authorization by physicians recommended by
the breast tumour program


HYDROCORTISONE SODIUM SUCCINATE

     1

injectable

  intrathecal use only


HYDROXYUREA
     1
capsules



IDARUBICIN
     3
injectable
POG Protocol 9720
prescribing limited to written authorization by physicians recommended by
the pediatric tumour program


IFOSFAMIDE
     1
     2
injectable
pump



IMATINIB
     2
capsules
  for surgically unresectable or metastatic gastrointestinal stromal tumour
(GIST)
  prescribing limited to written authorization by named physicians as
recommended by the tumour program



     2
capsules
Hematology
  Philadelphia-chromosome positive leukemia (including disease situations
such as first chronic phase chronic myelogenous leukemia (CML), accelerated
phase CML, blast crisis phase CML, acute lymphoblastic leukemia, or other
leukemias that have the characteristic t(9;22) translocation detected by
cytogenetics, FISH analysis, or PCR-positive for bcr-abl oncogene)
  prescribing limited to written authorization by named physicians as
recommended by the hematology/lymphoma program


INTERFERON


  - alpha 2a or 2b

  - alpha 2b in new patients "03-04"
     1
injectable
  cladribine-resistant hairy cell leukemia
  Kaposi's sarcoma
  chronic myelogenous leukemia
  metastatic renal cell carcinoma



INTERFERON
  alpha 2a ONLY
     1
injectable
  mycosis fungoides and sezary syndrome (cutaneous T-cell lymphomas)
  prescribing limited to written authorization by physicians recommended by
the hematology/lymphoma tumour program


INTERFERON
 alpha 2b ONLY
     1
injectable
  basal cell carcinoma
  adjuvant treatment of high risk melanoma



     1
injectable
Superficial Bladder Cancer
  Interferon alone - second line treatment or first line in those with a
documented intolerance or contraindication (i.e., immunosuppression or
other) to BCG
  Interferon in combination with BCG - second line treatment



     2
injectable
  treatment of patients with malignant carcinoid and neuroendocrine
gastroenteropancreatic tumours not amenable to surgical extirpation
  prescribing limited to written authorization by physicians recommended by
the GI and endocrine tumour programs



     2
injectable
  maintenance therapy in multiple myeloma patients who have achieved
complete remission after high dose chemotherapy and autologous stem cell
transplant
  follicular lymphoma and need for therapy as indicated by any of: mass >7
cm or 3 sites >3 cm, Bsx, splenomegaly @ umbilicus, compression syndromes
(GI, GU, orbit), effusions cytopenias, Age < 70 yo
  prescribing limited to written authorization by physicians recommended by
the hematology/lymphoma tumour program


IRINOTECAN

*  NOTE:
Loperamide supplied by industry with this agent's use
     2
injectable
Metastatic Colorectal Cancer
  first line (with 5FU and leucovorin)
  2nd line after failure of thymidilate synthase inhibitors (e.g., 5
fluorouracil, raltitrexed, or capecitabine)
  prescribing limited to written authorization by physicians recommended by
the GI tumour program



     2
injectable
Pediatrics
  restricted to the treatment of high risk metastatic rhabdomyosarcomas
following POG/CCG protocols
  prescribing limited to written authorization by physicians recommended by
the pediatric tumour program


LETROZOLE
     1
tablets
  first line therapy for hormone receptor positive post-menopausal
metastatic breast cancer


LEUCOVORIN CALCIUM
     1
injectable, tablets
  rescue therapy for methotrexate only
  in combination with 5FU


LEUPROLIDE
     1
injectable
  prostate cancer
  Restricted to:
Stage II (T2a-T2c): Neoadjuvant use pre RT (2 months pre and during RT).
Neoadjuvant use pre radical prostatectomy (4 months pre)
Stage III (T3a-T4b): Neoadjuvant use pre RT (2 months pre and during RT).
Adjuvant use (3 years post RT)
Stage IV (N1-N3) (M1-M1c): As monotherpy in medical castration.
In total androgen blockade (medical castration and nonsteriodal
antiandrogen)
  Guidelines for LHRH use in the above stated stages include: LHRH agonists
are indicated for use in patients at risk of thromboembolic disease,
strokes (CVA), myocardial infarction and also for consideration in patients
with dyslipidemia, hypertension, diabetes mellitus or where a patient is
considered intolerant to cyproterone acetate or megestrol acetate


LOMUSTINE
     1
capsules



MECHLORETHAMINE
     1
injectable, topical



MEDROXYPROGESTERONE ACETATE
     1
tablets, injectable



MEGESTROL ACETATE
     1
tablets



MELPHALAN
     1
tablets



MERCAPTOPURINE
     1
tablets



MESNA
     1
injectable



METHOTREXATE
     1
injectable, tablets



MITOMYCIN
     1
injectable
NOTE:  3rd line for bladder cancer indication


MITOXANTRONE
     1
injectable



NANDROLONE DECANOATE
     1
injectable



NILUTAMIDE
     1
tablets
  prostate cancer


PACLITAXEL
     2
injectable
Ovarian Cancer
  first line treatment of ovarian cancer (irrespective of the stage of
disease or amount of residual disease), fallopian tube carcinoma, primary
peritoneal neoplasms and papillary serous and clear cell endometrial
carcinomas
  prescribing limited to written authorization by physicians recommended by
the gynecology tumour program



     2
injectable
Endometrial Cancer
  restricted for use in metastatic, advanced or recurrent endometrial
cancer
  prescribing limited to written authorization by named physicians as
recommended by the gynecology tumour program



     2
injectable
Lung Cancer
  prescribing limited to written authorization by physicians recommended by
the lung tumour program



     2
injectable
Breast Cancer
  restricted to the treatment of metastatic breast cancer when no response
to anthracycline (doxorubicin, epirubicin, or mitoxantrone) containing
regimen. Relapse within 1 year after completion of adjuvant chemotherapy
including an anthracycline. First assessment of efficacy after 2 courses.
  only one taxane is to be administered to any one patient
  prescribing limited to written authorization by physicians recommended by
the breast tumour program



     2
injectable
Breast Cancer Adjuvant
  Doxorubicin/ Cyclophosphamide followed by Paclitaxel as an option for
adjuvant therapy of Stage II, node positive or high risk node negative
breast cancer
  prescribing limited to written authorization by named physicians as
recommended by the breast tumour program



     2
injectable
Testes
  2nd line regimen for relapsed germ cell tumours of the testes



     2
injectable
  in combination chemotherapy for unknown primary metastatic adenocarcinoma
  prescribing limited to written authorization by named physicians as
recommended by the breast and hematology tumour programs


PAMIDRONATE
     1
injectable
  treatment of multiple myeloma


PEG ASPARAGINASE
     3
injectable
  prescribing limited to written authorization by physicians recommended by
the pediatric tumour program as per POG protocols


PREDNISOLONE SODIUM PHOSPHATE
     1
liquid
  first line agent for pediatric patients under 7 years of age
  2nd-line agent for pediatric patients 7 years and older unable to
tolerate prednisone tablets


PREDNISONE
     1
tablets



PROCARBAZINE
     1
capsules



RALTITREXED
     2
injectable
  treatment of metastatic colorectal cancer
  prescribing limited to written authorization by physicians recommended by
the GI tumour program


RITAXIMAB
     2
injectable
  relapsed or refractory, low grade or follicular, CD20 positive, B-cell,
non-Hodgkin's  lymphoma
  prescribing limited to written authorization by physicians recommended by
the lymphoma tumour program



     2
injectable
  in combination with CHOP for aggressive histology B-cell CD20 positive
non-hodgkin's lymphoma in patients 60 years of age or older
  prescribing limited to written authorization by named physicians as
recommended by the hematology/lymphoma tumour program



     2
injectable
  for Post Transplant Lymphoproliferative Disorders (PTLD)
  prescribing limited to written authorization by named physicians as
recommended by the hematology tumour program


STREPTOZOCIN
     1
injectable



TAMOXIFEN
     1
tablets



TEMOZOLOMIDE
     2
oral
  first-line treatment of recurrent glioblastoma multiforme and anaplastic
astrocytoma
  prescribing limited to written authorization by physicians recommended by
the neuro oncology tumour program


TENIPOSIDE
     1
injectable



THALIDOMIDE
     3
oral
  in refractory multiple myeloma
  Special Access Program, Health Protection Branch
  prescribing limited to written authorization by named physicians as
recommended by the lymphoma tumour program


THIOGUANINE
     1
tablets



THIOTEPA
     2
injectable



TOPOTECAN
     2
injectable
Ovarian
  advanced epithelial ovarian cancer as 2nd line therapy
  prescribing limited to written authorization by physicians recommended by
the gynecology tumour program
Pediatrics
  restricted to the treatment of advanced stage neuroblastoma following
POG/CCG Protocols
  restricted to the treatment of intermediate risk rhabdomyosarcoma
following POG/CCG protocols
  prescribing limited to written authorization by physicians recommended by
the pediatric tumour program


TRASTUZUMAB
     2
injectable
Metastatic Breast
  restricted to the treatment of metastatic breast cancer, HER 2 protein
overexpression (+3)
  prescribing limited to written authorization by physicians recommended by
the breast tumour program


VALRUBICIN
     2
injectable
  for BCG refractory carcinoma in situ, defined as persistent disease after
2 courses of BCG or intolerance (severe side effects, immunosuppression,
etc.) to treatment with BCG


VINBLASTINE
     1
injectable



VINCRISTINE
     1
injectable



VINORELBINE
     2
injectable
Lung Cancer
  restricted to the treatment of advanced or metastatic non-small cell lung
cancer with an ECOG score of 2 or better
  prescribing limited to written authorization by physicians recommended by
the lung tumour program



     2
injectable
Metastatic Breast
  first-line therapy for elderly patients (over 65 years of age) and 2nd or
3rd line therapy for metastatic breast cancer.  Assess response after 2
cycles
  prescribing limited to written authorization by physicians recommended by
the breast tumour program


     ------------------------------

     Alberta Regulation 294/2003

     Alberta Evidence Act

     QUALITY ASSURANCE COMMITTEE REGULATION

     Filed:  October 7, 2003

Made by the Lieutenant Governor in Council (O.C. 439/2003) on October 7,
2003 pursuant to section 9 of the Alberta Evidence Act.


Quality assurance committees
1   The following are designated as quality assurance committees for the
purposes of section 9 of the Alberta Evidence Act:

     (a)  the Committee on Reproductive Care established by the Alberta
Medical Association (C.M.A. Alberta Division);

     (b)  the Physicians Performance Committee established by the College
of Physicians and Surgeons of Alberta;

     (c)  the Perinatal Morbidity Review Committee established by the
Northern and Central Alberta Perinatal Program Advisory Committee;

     (d)  the Ambulance Medical Review Committee established by
Ministerial Order under section 7 of the Government Organization Act.


Expiry
2   For the purpose of ensuring that this Regulation is reviewed for
ongoing relevancy and necessity, with the option that it may be repassed in
its present or an amended form following a review, this Regulation expires
on August 1, 2012.


Repeal
3   The Medical Committee Regulation (AR 370/85) is repealed.


     ------------------------------

     Alberta Regulation 295/2003

     Health Insurance Premiums Act

     PENALTY REGULATION

     Filed:  October 7, 2003

Made by the Lieutenant Governor in Council (O.C. 442/2003) on October 7,
2003 pursuant to section 2 of the Health Insurance Premiums Act.


     Table of Contents

Definition     1
Calculation of penalty   2
Individuals re premiums  3
Individuals re premium subsidy     4
Agents    5
Repeal    6
Expiry    7


Definition
1   In this Regulation, "Act" means the Health Insurance Premiums Act.


Calculation of penalty
2   A penalty imposed under section 18 of the Act shall be calculated in
accordance with this Regulation.


Individuals re premiums
3(1)  If the amount owing under the Act by a registrant who is liable to
pay premiums other than as a member of a group is equal to or exceeds the
premiums payable for a 3-month period, a penalty of 4.5% of the amount
owing may be assessed.

(2)  A penalty may be assessed under subsection (1) at the end of each
3-month period following the non-payment of an amount owing under the Act.


Individuals re premium subsidy
4(1)  If an amount owing under the Act by a registrant is in respect of a
premium subsidy obtained by the registrant for which the registrant was not
eligible, a penalty of 4.5% of the amount owing may be assessed.

(2)  A penalty may be assessed under subsection (1) at the end of each
3-month period following the non-payment of the amount owing under the Act.


Agents
5(1)  If the amount owing under the Act by an agent is not paid on or
before the payment due date shown in the monthly premium statement that is
sent to the agent, a penalty equal to the greater of the following may be
assessed:

     (a)  $20;

     (b)  1.5% of the amount owing.

(2)  A penalty may be assessed under subsection (1) at the end of each
month following the non-payment of an amount owing under the Act.


Repeal
6   The Penalty Regulation (AR 29/88) is repealed.


Expiry
7   For the purpose of ensuring that this Regulation is reviewed for
ongoing relevancy and necessity, with the option that it may be repassed in
its present or an amended form following a review, this Regulation expires
on July 1, 2012.


     ------------------------------

     Alberta Regulation 296/2003

     Public Health Act

     CO-ORDINATED HOME CARE PROGRAM REGULATION

     Filed:  October 7, 2003

Made by the Lieutenant Governor in Council (O.C. 444/2003) on October 7,
2003 pursuant to section 66 of the Public Health Act.


     Table of Contents

Definitions    1
Program   2
Requirements for admission    3
Appointment and duties of a manager     4
Provision of services    5
Records and reports to Minister    6
Reimbursement  7
Fees 8
Repeal    9
Expiry    10

Definitions
1   In this Regulation,

     (a)  "Act" means the Public Health Act; 

     (b)  "health care service" means any one or more of the following:

               (i)  nursing service;

               (ii) rehabilitation therapy service;

               (iii)     health care procedures authorized and supervised by
a nurse or a rehabilitation therapist;

     (c)  "homemaking service" means any one or more of the following:

               (i)  adult sitting and child care;

               (ii) routine housecleaning, laundry, ironing or mending;

               (iii)     budgeting, banking, paying bills or shopping for
essentials;

               (iv) menu planning or meal preparation;

               (v)  any other home management service;

     (d)  "manager" means a program manager appointed under section 4;

     (e)  "palliative care client" means a client for whom treatment
aimed at cure is no longer appropriate, but for whom treatment and care
aimed at maintaining and improving the quality of the remaining life are
primary objectives;

     (f)  "personal care service" means either or both of the following:

               (i)  personal hygiene care;

               (ii) assistance with the personal activities of daily
living;

     (g)  "program" means a co-ordinated home care program provided under
this Regulation;

     (h)  "rehabilitation therapy service" means service provided by a
physiotherapist, an occupational therapist, a speech pathologist or a
respiratory technologist;

     (i)  "support service" means any one or more of the following:

               (i)  personal care service;

               (ii) homemaking service;

               (iii)     heavy housework service;

               (iv) handyman service;

               (v)  the services commonly known as "Meals on Wheels"
and "Wheels to Meals";

               (vi) transportation service.


Program
2(1)  Where a program is approved by the Minister, a regional health
authority shall provide the program in accordance with this Regulation.

(2)  A regional health authority shall ensure that its program is
co-ordinated with other agencies providing similar health care and support
services.

(3)  A program shall provide

     (a)  nursing service,

     (b)  personal care service, and

     (c)  homemaking service.

(4)  A program may provide the following services:

     (a)  rehabilitation therapy service;

     (b)  dressings, medications and other related preparations;

     (c)  the temporary use of a health aid not provided under the
Alberta Aids to Daily Living and Extended Health Benefits Regulation under
the Act;

     (d)  heavy housework service;

     (e)  handyman service;

     (f)  the services commonly known as "Meals on Wheels" and "Wheels to
Meals";

     (g)  transportation service;

     (h)  nutrition service.

(5)  Where a program provides health care services and support services,
the regional health authority shall ensure that those services are made
available to all palliative care clients admitted to the program.

(6)  A regional health authority shall use volunteers to the fullest extent
possible in its program.


Requirements for admission
3(1)  Subject to this section, a person may be admitted to a program when 

     (a)  the manager is satisfied that

               (i)  the person has been assessed as requiring a health
care service or a support service, 

               (ii) the person's home is suitable for the provision of
a health care service or a support service, 

               (iii)     the program is the most suitable method of
providing the amount, level and type of any health care service or support
service required by the person,

               (iv) the resources and the budget of the program are
sufficient to meet the assessed needs of the person,

               (v)  the cost of providing any health care service or
support service to the person assessed as being required under subclause
(i) will not exceed $3000 per month, and 

               (vi) the person does not require the services of a
health care professional 24 hours a day on a continuing basis, 

     (b)  the person is a resident of Alberta as defined in the Alberta
Health Care Insurance Act.

(2)  Notwithstanding subsection (1)(b), if a person otherwise meets the
requirements of subsection (1), the person may be admitted to the program
if the person agrees to pay for the cost of any health care service or
support service provided, including related administrative costs, as
assessed by the regional health authority.

(3)  Notwithstanding subsection (1)(a)(v) and (vi), if a person otherwise
meets the requirements of this section, the person may be admitted to the
program 

     (a)  if awaiting placement in a health care facility, 

     (b)  if the person is, in the opinion of the manager, a palliative
care client, or 

     (c)  if, in the opinion of the manager, the provision of additional
health care services and support services may avoid institutional placement
and the period for which the additional services are required does not
exceed 3 months in a calendar year.

(4)  A person who is refused admission to a program by a manager under
subsection (1)(a) may apply to the regional health authority for a review
of that decision.


Appointment and duties of a manager
4(1)  A regional health authority shall appoint, as a member of the
regional health authority staff, a manager who shall do the following:

     (a)  determine, in accordance with the requirements of section 3,
the eligibility of a person for admission to the program;

     (b)  case co-ordinate with respect to each client in relation to the
following matters: 

               (i)  general assessment of client needs;

               (ii) development of a care plan that designates any
health care services and support services required by the client;

               (iii)     monitoring and re-assessing the client's progress
with respect to the care plan;

               (iv) co-ordinating with other agencies providing
services to the client;

               (v)  determining the time of discharge of a client from
the program and carrying out a discharge plan;

     (c)  determine, in accordance with this Regulation, the amount of
any fee to be paid for any support service provided to the client under the
program.

(2)  A manager shall keep a record, in a manner acceptable to the Minister,
for each client admitted to the program respecting

     (a)  the general assessment carried out pursuant to subsection
(1)(b)(i), and

     (b)  the development of the care plan pursuant to subsection
(1)(b)(ii).

(3)  A manager shall keep a record, in a manner acceptable to the Minister,
respecting each person referred to the program but not admitted, and that
record shall describe the reasons for non-admission to the program for each
such person.


Provision of services
5   When a client is admitted to a program under section 3, the regional
health authority may provide the health care services and support services
that are authorized under this Regulation to that client.


Records and reports to Minister
6   A regional health authority shall submit to the Minister, in the form
and manner and at the time prescribed by the Minister, records and reports
respecting the operation of the program.


Reimburse-ment
7   Where a person receives a benefit under

     (a)  the Department of Veterans' Affairs Act (Canada),

     (b)  the Blue Cross Plan,

     (c)  the Group Surgical Medical Insurance Plan operated pursuant to
Treasury Board Minute No. 758836 of the Government of Canada dated July 7,
1978,

     (d)  the Workers' Compensation Act,

     (e)  the Motor Vehicle Accident Claims Act,

     (f)  the Victims of Crime Act, or

     (g)  any private insurance program 

in respect of a condition for which the person is also receiving a service
under this Regulation, the person shall reimburse the regional health
authority for the cost of the service provided under this Regulation in an
amount equal to the lesser of

     (h)  the cost of providing the service under this Regulation, and

     (i)  the amount the person receives under clauses (a) to (g),

as assessed by the regional health authority.


Fees
8(1)  Subject to this section, a client who receives support services,
other than personal care service, shall pay the fee prescribed in this
section.

(2)  A client who receives a support service other than a personal care
service shall pay the fee set by the Minister and shall pay the fee
monthly.

(3)  When a client receives the support service commonly known as "Meals on
Wheels" or "Wheels to Meals", the fees set by the Minister are applicable
on a per meal basis.

(4)  When a client receives a support service other than "Meals on Wheels"
or "Wheels to Meals", the fees set by the Minister are applicable on an
hourly basis.

(5)  No fee is chargeable for any support services provided to the client,
the client's spouse or adult independent partner or the client's dependants
under this Regulation where the client is in receipt of

     (a)  a social allowance provided under Part 2 of the Social
Development Act,

     (b)  a widow's pension under the Widows' Pension Act, 

     (c)  a Guaranteed Income Supplement provided under the Old Age
Security Act (Canada), or

     (d)  a benefit under the Assured Income for the Severely Handicapped
Act.

(6)  On application by a client, the regional health authority may waive
the payment of the whole or any part of the fees payable by the client
under this section where the regional health authority is of the opinion
that to require payment of the fees would cause undue financial hardship. 


Repeal
9   The Co-ordinated Home Care Program Regulation (AR 239/85) is repealed.


Expiry
10   For the purpose of ensuring that this Regulation is reviewed for
ongoing relevancy and necessity, with the option that it may be repassed in
its present or an amended form following a review, this Regulation expires
on October 31, 2012.


     ------------------------------

     Alberta Regulation 297/2003

     Public Health Act

     TREATMENT SERVICES AMENDMENT REGULATION

     Filed:  October 7, 2003

Made by the Lieutenant Governor in Council (O.C. 445/2003) on October 7,
2003 pursuant to section 66 of the Public Health Act.


1   The Treatment Services Regulation (AR 248/85) is amended by this
Regulation.


2   Section 1(a) is amended by striking out "Cleft Lip Palate" and
substituting "Congenital Cleft".


3   Section 2 is amended

     (a)  in subsection (1)

               (i)  by striking out "Cleft Lip Palate dental services"
and substituting "Congenital Cleft dental services";

               (ii) in clause (b) by striking out "registered in" and
substituting "registered at";

               (iii)     in clause (c) by striking out "lip palate syndrome"
and substituting "of the alveolar ridge";

     (b)  in subsection (2) by striking out "congenital cleft lip palate
syndrome" and substituting "a congenital cleft of the alveolar ridge".


4   The following is added after section 7:

Expiry
     8   For the purpose of ensuring that this Regulation is reviewed for
ongoing relevancy and necessity, with the option that it may be repassed in
its present or an amended form following a review, this Regulation expires
on November 30, 2012.


     ------------------------------

     Alberta Regulation 298/2003

     Public Health Act

     WAIVER REGULATION

     Filed:  October 7, 2003

Made by the Lieutenant Governor in Council (O.C. 446/2003) on October 7,
2003 pursuant to section 66 of the Public Health Act.


     Table of Contents

List of regulations that may be waived or mitigated
   against by request    1
Requirements of request  2
Hearing by regional health authority    3
Order     4
Decision rendered within reasonable time     5
Conflict of interest     6
Appeal of decision  7
Delegation not authorized     8
Subcommittee   9
Repeal    10
Expiry    11


List of regulations that may be waived or mitigated against by request
1(1)  A person to whom a provision of any of the following regulations
under the Act applies may make a request to the regional health authority
for an order waiving or mitigating the application of the provision:

     (a)  the Food Regulation (AR 240/85);

     (b)  the Housing Regulation (AR 173/99);

     (c)  the Institutions Regulation, 1981 (AR 143/81);

     (d)  the Nuisance and General Sanitation Regulation (AR 243/2003);

     (e)  the Personal Services Regulation (AR 20/2003);

     (f)  the Recreation Area Regulation (AR 245/85);

     (g)  the Swimming Pool Regulation (AR 247/85), except section 10;

     (h)  the Work Camps Regulation (AR 218/2002).

(2)  A regional health authority may not grant an order waiving a
requirement for a licence, permit or approval in a regulation.


Requirements of request
2   A request under section 1 must

     (a)  be in writing and be made to the chair of the appropriate
regional health authority,

     (b)  refer to the regulation and the provision for which the waiver
or mitigation is requested,

     (c)  state the reason for the request, and

     (d)  be served on the regional health authority by leaving it at any
office of the regional health authority.


Hearing by regional health authority
3(1)  The regional health authority shall hold a hearing to consider the
request within 30 days after it receives the request.

(2)  Notwithstanding subsection (1), the regional health authority may,
with the consent of the applicant, extend the time referred to in
subsection (1) for additional periods, each not exceeding 30 days.

(3)  The regional health authority may adjourn a hearing.

(4)  A hearing must be open to the public unless the regional health
authority directs otherwise.

(5)  The regional health authority shall give reasonable notice of the
time, date and place of the hearing to

     (a)  the applicant, and

     (b)  any other person who, in the opinion of the regional health
authority, is or may be affected by the decision

and shall afford the persons referred to in clauses (a) and (b) and any
other person who the regional health authority considers has an interest in
the subject-matter of the hearing an opportunity to make oral or written
representations to the regional health authority.


Order
4(1)  The regional health authority may grant an order waiving or
mitigating the application of a provision of a regulation where it is
satisfied that

     (a)  application of the provision would cause a hardship to the
applicant in the particular case, and

     (b)  an adequate degree of protection of the public health would be
maintained.

(2)  The regional health authority may make an order under subsection (1)
subject to any terms and conditions the regional health authority considers
appropriate to ensure an adequate degree of protection of the public
health.

(3)  An order under subsection (1) must be limited to the particular case
in respect of which the application was made.


Decision rendered within reasonable time
5   The regional health authority shall, within a reasonable time after the
conclusion of a hearing under this Regulation, make a decision and serve a
copy of the decision, together with reasons, on the applicant and the
persons who made representations at the hearing.


Conflict of interest
6   No member of a regional health authority shall participate in a hearing
under this Regulation if the member has a pecuniary interest, whether
direct or indirect, in the subject-matter of the application.


Appeal of decision
7   A person who is directly affected by a decision of a regional health
authority to grant or refuse an order under this Regulation and considers
himself or herself aggrieved by the decision may appeal the decision to the
Public Health Appeal Board under section 5 of the Act.


Delegation not authorized
8   A regional health authority shall not delegate to any of its employees
or officers any of its powers, duties or functions under this Regulation.


Subcommittee
9   A regional health authority may establish one or more subcommittees of
at least 3 members to hear and decide applications under this Regulation.


Repeal
10   The Waiver Regulation (AR 249/85) is repealed.


Expiry
11   For the purpose of ensuring that this Regulation is reviewed for
ongoing relevancy and necessity, with the option that it may be repassed in
its present or an amended form following a review, this Regulation expires
on October 31, 2012.


     ------------------------------

     Alberta Regulation 299/2003

     Livestock Diseases Act

     PRODUCTION ANIMAL MEDICINE REGULATION

     Filed:  October 7, 2003

Made by the Lieutenant Governor in Council (O.C. 447/2003) on October 7,
2003 pursuant to section 9 of the Livestock Diseases Act.


     Table of Contents

Definitions    1
Application of Regulation     2
Licence required    3
Application for licence  4
Renewal of licence  5
Refusal to issue or renew licence  6
Term of licence     7
Licence non-transferable 8
Change in ownership 9
Notices   10
Fee not refundable  11
Qualification certificate required 12
Permitted medicine  13
Suspension or cancellation of licence   14
Records and reports 15
Inspection of records    16
Inspection of medicines and premises    17
Manner of sale 18
Advertising    19
Storage of medicine 20
Other duties of licensee 21
Restricting sale of other products 22
Businesses must be kept separate   23
Form of notice of appeal 24
Repeal    25
Expiry    26

Schedule


Definitions
1   In this Regulation,

     (a)  "Act" means the Livestock Diseases Act;

     (b)  "active pharmaceutical ingredients" means bulk pharmaceutically
active substances used in the formulation of medicines in dosage forms;

     (c)  "Committee" means the Advisory Committee established by the
Minister under section 7 of the Government Organization Act for the
purposes of this Regulation;

     (d)  "Department" means the Department of Agriculture, Food and
Rural Development;

     (e)  "end user" means a person who administers medicine to a
production animal;

     (f)  "licence" means a licence issued under this Regulation to sell
medicine to the public;

     (g)  "licensee" means a person who holds a licence issued under this
Regulation;

     (h)  "medicine" means

               (i)  a biological,

               (ii) a product that has been assigned a Drug
Identification Number (DIN) under the Food and Drugs Act (Canada), or

               (iii)     a product that contains a Pest Control Product
number that is intended for direct application to a production animal,
including, without limitation, insecticide impregnated ear tags;

     (i)  "permanent place of retail business" means a business operated
in a building or a part of a building that

               (i)  is accessible to the public during regular business
hours of not less than 40 hours per week, and

               (ii) has signs or other markings that identify the
building or a part of the building as a place of retail business,

          but does not include a business operated in a private dwelling
or in a building used to permanently house production animals;

     (j)  "production animal" means

               (i)  a species of animal that may be used for human
consumption or whose products may be used for human consumption,

               (ii) a fur-bearing animal referred to in section 1 of
the Fur Farms Regulation (AR 299/96), or

               (iii)     a species of animal used for crop pollination;

     (k)  "sell" includes offer for sale, expose for sale and have in
possession for sale and distribution, whether or not the distribution is
made for consideration;

     (l)  "wholesaler" means a person who sells medicine to persons other
than end users.


Application of Regulation
2   This Regulation does not apply to

     (a)  the sale of medicated feeds prepared either in accordance with
the Feeds Act (Canada) or pursuant to a prescription issued by a registered
veterinarian, or

     (b)  the sale of medicine by a manufacturer or wholesaler of
medicine to

               (i)  a registered veterinarian or a pharmacist,

               (ii) another manufacturer or wholesaler of medicine, or

               (iii)     a licensee.


Licence required
3   No person shall sell medicine to the public except under the authority
of a licence issued under this Regulation.


Application for licence
4(1)  A person wishing to apply for a licence must submit a completed
application in the form provided by the Director, accompanied with

     (a)  a copy of the applicant's retail business licence acceptable to
the Director or, in a case where the local authority does not issue retail
business licences, a letter or a copy of a development permit from the
local authority indicating that the applicant has authority to operate a
retail business,

     (b)  such other information as required by the Director,

     (c)  an application fee in an amount set by the Director, and

     (d)  a licence fee in an amount set by the Director, payable on
approval of the application.

(2)  The Director may refer to the Committee, for its review and
recommendations, any application for a licence that, in the opinion of the
Director, is unusual.


Renewal of licence
5   A person wishing to apply for a renewal of licence must submit a
completed application in the form provided by the Director, accompanied
with a licence renewal fee in an amount set by the Director.


Refusal to issue or renew licence
6(1)  The Director may refuse to issue or renew a licence if the Director
is of the opinion that the applicant

     (a)  does not have a permanent place of retail business or otherwise
lacks the equipment and facilities required to properly sell medicine to
the public, or

     (b)  has contravened

               (i)  the Act or this Regulation,

               (ii) the Pharmaceutical Profession Act,

               (iii)     the Veterinary Profession Act, or

               (iv) any Act of the Parliament of Canada relating to the
sale or distribution of medicine.

(2)  If the Director refuses to issue or renew a licence, the Director
shall notify the applicant in writing of that fact.


Term of licence
7   A licence expires on December 31 of the year for which it is issued.


Licence non-transferable
8   A licence is not assignable or in any other manner transferable.


Change in ownership
9(1)  On a change of ownership of a licensee's business, the licensee shall
notify the Director forthwith and return the unexpired licence to the
Director.

(2)  For the purposes of subsection (1),

     (a)  in the case of a licence issued to a partnership, a change in
ownership is deemed to have occurred if there is a change in the partners
of the partnership;

     (b)  in the case of a licence issued to a corporation, a change in
ownership is deemed to have occurred if 50% or more of the beneficial
ownership of the shares in the corporation is sold, assigned or
transferred.


Notices
10   A notice to be given to a licensee by either the Minister or the
Director under this Regulation may be given by personal service or by
registered mail addressed to the licensee's last known address for service.


Fee not refundable
11(1)  Subject to subsection (2), any fee paid under this Regulation is not
refundable.

(2)  Where the Director refuses to issue or renew a licence under section
6, the Director shall return the licence fee or licence renewal fee, as the
case may be, to the applicant.


Qualification certificate required
12(1)  No licensee shall sell medicine unless the licensee has on duty
during regular business hours at least one staff member who holds a
qualification certificate.

(2)  A person may apply to the Director for a qualification certificate.

(3)  The Director shall issue a qualification certificate to an applicant
who has

     (a)  successfully completed any course of instruction or training
regarding the proper handling of medicine that is required by the Director,

     (b)  passed an examination set by the Committee, and

     (c)  paid a fee for making the application in an amount set by the
Director.

(4)  A qualification certificate expires on December 31 of the 5th year
following the year in which the certificate was issued.

(5)  A licensee shall notify the Director forthwith of

     (a)  ceasing to have a staff member who holds a qualification
certificate as required by subsection (1), or

     (b)  the name and qualification certificate number of any new staff
member on the applicant's premises who holds a qualification certificate.


Permitted medicine
13(1)  Subject to subsections (2) and (3), a licence issued under this
Regulation authorizes the licensee to sell any of the following medicine:

     (a)  injectable biologicals for the prevention or treatment of
disease in production animals, including antiserums, bacterins, toxoids,
antitoxins, products containing concentrated or purified antibodies and
vaccines, except Brucella, Rabies, Anthrax, modified-live virus and live
virus vaccines for mammals;

     (b)  antibiotics for administration to production animals and
sulfonamides and their salts and derivatives listed or described in Part
II, Schedule F of the Food and Drug Regulations (C.R.C., 1978 c.870) made
under the Food and Drugs Act (Canada), including drug preparations listed
in the Compendium of Medicating Ingredients Brochure (MIB) published by the
Canadian Food Inspection Agency;

     (c)  preparations for the control of external and internal parasites
and insect pests of production animals, including those registered under
the Pest Control Products Act (Canada);

     (d)  oral preparations labelled by the manufacturer for the
prevention or treatment of diseases of the digestive system in production
animals, including bloat, colic, indigestion, diarrhea, constipation and
impaction;

     (e)  preparations labelled by the manufacturer for the treatment of
surface wounds and lacerations, wire cuts and burns in production animals;

     (f)  preparations labelled by the manufacturer for the treatment of
skin diseases in production animals, including topical hoof care products;

     (g)  vitamins for injection or oral administration to production
animals, injectable vitamin A not to exceed 500 000 I.U. per millilitre and
injectable vitamin D not to exceed 75 000 I.U. per millilitre;

     (h)  preparations containing minerals for oral administration, and
selenium and iron for injection into production animals for the prevention
or treatment of deficiencies, including hematinics for horses containing
not more than 1 milligram of copper gluconate or cobalt gluconate, or both;

     (i)  growth promotants in the form of implants and feed additives
labelled by the manufacturer for use in production animals;

     (j)  injectable epinephrine for treatment of anaphylactic reactions
in production animals;

     (k)  dextrose, calcium, phosphorus and magnesium preparations and
propylene glycol labelled by the manufacturer for treatment and prevention
of acetonemia and hypocalcemia in production animals and preparations
intended as an aid in the supportive treatment of nutritional deficiencies
in debilitated production animals;

     (l)  anti-cannibalism compounds for poultry;

     (m)  topical preparations labelled by the manufacturer as liniments,
counter-irritants or poultices for the treatment of joint pain, swollen
ligaments, tendons or muscles;

     (n)  oral or topical preparations labelled by the manufacturer as
antitussives, decongestants, brochodilators or expectorants;

     (o)  acetylsalicylic acid boluses for horses and cattle;

     (p)  disinfectants, udder washes and teat dips and sanitizers.

(2)  No licensee shall

     (a)  purchase or sell a medicine not listed in subsection (1),

     (b)  sell a medicine listed in subsection (1) that is listed or
described as a drug in Part I, Schedule F of the Food and Drug Regulations
(C.R.C., 1978 c.870) made under the Food and Drugs Act (Canada), or

     (c)  permit a medicine, including active pharmaceutical ingredients,
not listed in subsection (1) to be stored at the licensee's permanent place
of retail business.

(3)  No licensee shall sell a medicine listed in subsection (1) that has
been imported from a jurisdiction outside Canada unless the medicine has
first been approved by the Veterinary Drug Directorate of Health Canada.


Suspension or cancellation of licence
14(1)  Where a licensee has made a false statement in the application for a
licence or renewal of a licence, or has contravened the Act or this
Regulation, the Pharmaceutical Profession Act, the Veterinary Profession
Act or any Act of the Parliament of Canada relating to the sale or
distribution of medicine, the Minister may

     (a)  request the licensee to provide a written undertaking, in a
form acceptable to the Minister, that the licensee will refrain from
engaging in the act or practice that gave rise to the contravention,

     (b)  suspend the licensee's licence for a period that the Minister
considers appropriate, or

     (c)  cancel the licensee's licence.

(2)  Where the Minister has suspended or cancelled a licensee's licence,
the Minister shall notify the licensee in writing of that fact.

(3)  Where the Minister has suspended or cancelled a licensee's licence,
the licensee shall

     (a)  remove all medicine from public display,

     (b)  provide the Director with a description and inventory of all
medicine in the licensee's possession,

     (c)  cease to carry on business until the licence is reinstated, and

     (d)  cease to purchase any further medicine.

(4)  Where the Minister has suspended or cancelled a licensee's licence,
the Minister may cause an inspector

     (a)  to seal the cabinet or storage space where the licensee's
medicine is kept, and

     (b)  to erect a placard within the licensee's business premises that
reads "Medicine for Diseases of Production Animals Not For Sale by order of
the Minister of Agriculture, Food and Rural Development".

(5)  No person other than an inspector shall remove a seal or placard
referred to in subsection (4).


Records and reports
15(1)  A licensee shall keep an accurate record for each medicine purchased
and sold by the licensee, including

     (a)  the date, name and address of the purchaser,

     (b)  the type and quantity of the medicine purchased, and

     (c)  such other records as the Director may require.

(2)  A licensee shall keep copies of all purchase receipts and records of
sales for a period of 2 years.

(3)  A licensee shall ensure that all records required to be kept by the
licensee under this section are readily available for inspection by an
inspector.

(4)  The Director may at any time require a written report from a licensee,
in a form satisfactory to the Director, containing information required by
Director.


Inspection of records
16(1)  On the request of an inspector, a licensee shall

     (a)  make available for inspection by the inspector any record
described in section 15, and

     (b)  provide copies of the records acceptable to the inspector or
permit the inspector to remove the records for the purpose of making copies
of them.

(2)  Where an inspector removes any records under subsection (1)(b), the
inspector shall

     (a)  leave a statement with the licensee specifying which records
have been removed for copying, and

     (b)  as soon as possible, make the required copies and return the
records to the licensee.


Inspection of medicines and premises
17(1)  A licensee shall permit an inspector to inspect during ordinary
business hours

     (a)  the medicine the licensee has in stock, and

     (b)  the premises where the medicine is stored and sold.

(2)  If an inspector during an inspection finds any medicine that is not
listed in section 13(1), the inspector shall

     (a)  direct the licensee to forthwith return the medicine to the
supplier of the medicine, or

     (b)  with the consent of the licensee take possession of the
medicine and dispose of it on the direction of the Director.


Manner of sale
18(1)  No licensee shall sell medicine in any manner other than over the
counter at the licensee's permanent place of retail business.

(2)  Without restricting the generality of subsection (1), no licensee
shall solicit the sale of medicine by mail order, Internet communication or
at a place other than the licensee's permanent place of retail business.

(3)  Subsection (1) does not apply to the sale of disinfectants, udder
washes and teat dips and sanitizers.


Advertising
19   A licensee, when advertising the sale of medicine, may

     (a)  use only the words "Medicine for Diseases of Production
Animals", and

     (b)  refer only to the factual information from the medicine label
or package insert of the medicine.


Storage of medicine
20(1)  A licensee shall store medicine for sale in a manner recommended by
the manufacturer of the medicine.

(2)  Without restricting the generality of subsection (1),

     (a)  a licensee shall store or display medicine for sale that does
not require refrigeration in a place that

               (i)  prevents the medicine from coming in contact with
any food or other medicine designated for human use, and

               (ii) is clean and sanitary at all times,

     and

     (b)  a licensee shall

               (i)  keep medicine for sale that requires refrigeration
in a refrigerator at the temperature recommended by the manufacturer of the
medicine, and

               (ii) ensure that the refrigerator

                         (A)  does not contain any food or other
medicine designated for human use, and

                         (B)  is clean and sanitary at all times.

(3)  A licensee shall ensure that all medicine for sale is stored and
handled in a manner that protects animals and their feed from being
contaminated with the medicine.


Other duties of licensee
21(1)  A licensee shall

     (a)  sell medicine only in containers labelled by the manufacturer,

     (b)  draw to the attention of a purchaser of medicine any
precautions to be taken with respect to the minimum amount of time that
must elapse

               (i)  between the administration of the medicine to a
production animal and the slaughter of the animal, and

               (ii) between the administration of the medicine to a
production animal and the time at which the products from the animal may be
used for human consumption,

     (c)  draw to the attention of a purchaser of medicine any toxicity
warnings or other precautions on the label,

     (d)  display a sign, in a form determined by the Director, in a
prominent location within the licensee's permanent place of retail business
that

               (i)  emphasizes the importance of proper use of
medicine, and

               (ii) refers customers to a staff person who holds a
qualification certificate for clarification of any questions regarding the
safe and proper use of medicine,

     and

     (e)  immediately after the expiration date of any medicine, remove
the medicine and keep it separate from other stock until it is destroyed or
returned to the supplier.

(2)  No licensee shall

     (a)  repackage or alter the contents of any medicine,

     (b)  give away, barter or sell any medicine as an inducement to
purchase other merchandise,

     (c)  sell medicine after the expiry date of the medicine,

     (d)  refuse a request to provide a receipt to any person who
purchases medicine, or

     (e)  diagnose, prescribe or otherwise contravene the Veterinary
Profession Act.

(3)  Despite subsection (1)(a), a licensee may sell individual boluses of
medicine if

     (a)  copies of the package inserts and suitable containers are
provided to the purchaser at the point of sale, and

     (b)  the containers are inscribed with the DIN, lot number and
expiry date of the medicine sold.


Restricting sale of other products
22   No licensee shall sell a product that, in the opinion of the Director,
poses a health risk to humans or animals.


Businesses must be kept separate
23   A licensee who is also licensed under another enactment to sell
medicine shall not carry on both businesses in the same permanent place of
retail business unless each business

     (a)  has its own entrance and exit separate from the entrance and
exit for the other business,

     (b)  operates under a unique name or a name that is distinct from
the name of the other business,

     (c)  has its own receiving and storage area separate from the
receiving and storage area for the other business, and

     (d)  uses separate invoices for the sale of its medicine and other
products.


Form of notice of appeal
24   The form of the notice of appeal required for the purposes of section
10(1) of the Act is as set out in the Schedule.


Repeal
25   The Production Animal Medicine Regulation (AR 31/98) is repealed.


Expiry
26   For the purpose of ensuring that this Regulation is reviewed for
ongoing relevancy and necessity, with the option that it may be repassed in
its present or an amended form following a review, this Regulation expires
on October 31, 2008.


     SCHEDULE

     Notice of Appeal


TO:  Minister of Agriculture, Food and Rural Development
     408 Legislature Building
     10800 - 97 Avenue
     Edmonton, Alberta
     T5K 2B6

TAKE NOTICE THAT   (name of appellant)   of    (address of appellant)   
wishes to appeal the decision of   (indicate either the Director or
Minister)   to   (indicate whether the decision was to refuse a licence, to
suspend a licence or to cancel a licence)  , dated the  (day)  of     (month)   ,   (year)  .

A copy of that decision is attached and forms part of this appeal.

The grounds for the appeal are as follows:
     (attach additional sheet if necessary)

DATED at _______, Alberta, this __ day of  (month) ,   (year)  .

               (Signature)          

FOR INFORMATION ONLY:

1.   In accordance with section 10 of the Livestock Diseases Act, a person
who has been refused a licence, or whose licence has been suspended or
cancelled may appeal the refusal, cancellation or suspension by serving a
notice of appeal on the Minister within 30 days of being notified in
writing of the refusal, cancellation or suspension.


     ------------------------------

     Alberta Regulation 300/2003

     Public Sector Pension Plans Act

     LOCAL AUTHORITIES PENSION PLAN (NEW EMPLOYERS, 2003)
     AMENDMENT REGULATION

     Filed:  October 7, 2003

Made by the Lieutenant Governor in Council (O.C. 448/2003) on October 7,
2003 pursuant to Schedule 1, section 4 of the Public Sector Pension Plans
Act.


1   The Local Authorities Pension Plan (AR 366/93) is amended by this
Regulation.


2   Part 1 of Schedule 2 is amended by adding the following in their
appropriate alphabetical order:

     Chinook Arch Library Board
     Lethbridge Housing Authority
     Raymond Irrigation District
     Slave Lake Air/Ground Ambulance Society


3   Section 2,

     (a)  as it applies to Chinook Arch Library Board, is deemed to have
come into force on January 1, 2003;

     (b)  as it applies to Lethbridge Housing Authority, is deemed to
have come into force on January 1, 2003;

     (c)  as it applies to Raymond Irrigation District, is deemed to have
come into force on April 1, 2003;

     (d)  as it applies to Slave Lake Air/Ground Ambulance Society, is
deemed to have come into force on April 1, 2003.


     Alberta Regulation 301/2003

     Public Sector Pension Plans Act

     PUBLIC SECTOR PENSION PLANS (MISCELLANEOUS 2004)
     AMENDMENT REGULATION

     Filed:  October 7, 2003

Made by the Lieutenant Governor in Council (O.C. 449/2003) on October 7,
2003 pursuant to Schedules 1, 2, 4 and 5, section 4 of the Public Sector
Pension Plans Act.


     Part 1
     Local Authorities Pension Plan

1   The Local Authorities Pension Plan (AR 366/93) is amended by this Part.


2   Section 2(1)(ss.2)  is amended by striking out "or" at the end of
subclause (i), adding ", or" at the end of subclause (ii) and adding the
following after subclause (ii):

     (iii)     attained the age of 65 years;


3   Section 11 is amended by repealing clause (c).


4   Section 33 is amended

     (a)  in subsection (2) by striking out ", or" at the end of clause
(a) and by repealing clause (b);

     (b)  by adding the following after subsection (2):

          (3)  Notwithstanding anything in this Part, a former
participant or the surviving pension partner of a deceased participant or
former participant who is entitled to select a pension or commuted value is
entitled, as an option, to be paid or to have transferred an amount equal
to the commuted value of the pension to which the former participant or
surviving pension partner is (or, in the case of a former participant to
whom sections 66 and 69 or 72 or all of those sections apply, will be)
entitled if

               (a)  the monthly payments of normal pension that would
or will be or that would have been payable to the former participant or the
deceased, as the case may be,

                         (i)  on reaching the age of 65 years, in the
case of a person who terminated or died, as the case may be, before
reaching that age, or

                         (ii) at termination or death, as the case
may be, in the case of a person who terminated or died having reached that
age,

                    do not exceed 1/12 of 4% of the year's maximum
pensionable earnings for the calendar year in which the termination or
death, as the case may be, occurred, or

               (b)  where payment or transfer of the commuted value
under Division 2 or 3, as the case may be, is allowed, the commuted value
to which that former participant or surviving pension partner is entitled
does not exceed 20% of that year's maximum pensionable earnings.

     (4)  In calculating the normal pension for the purposes of subsection
(3)(a) with reference to a person referred to in subsection (3)(a)(i), the
assumption as to reaching the age of 65 years

               (a)  is not to be taken to result in any increase in
pensionable service not actually performed, any actuarial increase on
postponement or any cost-of-living or any other adjustment, and

               (b)  in the case of a person who is entitled to a
pension under section 39 or 50, or both, is to be taken as negating the
reduction under that section or those sections.


5   Section 40 is amended by striking out "and who is vested".


6   Section 70 is amended

     (a)  by renumbering it as section 70(1);

     (b)  in subsection (1)(c) by striking out "73(c)" and substituting
"73(1)(c)";

     (c)  by adding the following after subsection (1):

          (2)  Notwithstanding subsection (1), if the person does not
make the choice under that subsection within 90 days after being requested
by the Minister to do so, the Minister shall pay the benefit under
subsection (1)(a).


7   Section 73 is amended

     (a)  by renumbering it as section 73(1);

     (b)  in subsection (1)(c) by striking out "70(c)" and substituting
"70(1)(c)";

     (c)  by adding the following after subsection (1):

          (2)  Section 70(2) applies.


8   Section 80 is amended

     (a)  by repealing subsections (1), (2) and (3) and substituting the
following:

Co-ordination of certain pensions with C.P.P. and O.A.S.
          80(1)  Where a person is to receive a pension commencing on or
after January 1, 2004 under section 36, 39, 39.1 or 69(d) before attaining
the age of 65 years, he may choose to increase the pension by an amount
equal to the actuarial equivalent of such amount as that person decides,
which amount so decided is in this section referred to, as applicable, as
the "decided amount" and is to be an amount not exceeding but decided by
reference to the maximum Canada Pension Plan retirement pension or the Old
Age Security benefit or both until he reaches the age of 65 years or dies
before reaching that age.

          (2)  Where a person is to receive a pension commencing on or
after January 1, 2004 under section 41(1) or 59(a)(i) before attaining the
age of 65 years, he may choose to increase the pension by an amount equal
to the actuarial equivalent of such amount as that person decides, which
amount so decided is in this section referred to, as applicable, as the
"decided amount" and is to be an amount not exceeding but decided by
reference to the maximum Old Age Security benefit until he reaches the age
of 65 years or dies before reaching that age.

          (2.1)  Where a person who has chosen to increase a pension
under subsection (1) or (2) attains the age of 65 years, the increased
pension, including the added amount, shall be reduced at that time by the
actuarial equivalent of the decided amount and, for (but only for) the
remainder of that person's lifetime, the pension shall be further reduced
from that time by the difference between the decided amount and the
actuarial equivalent of the decided amount.

          (2.2)  Where a person who has chosen to increase a pension
under subsection (1) or (2) dies before attaining the age of 65 years, the
increased pension, including the added amount, shall be reduced at that
time by the actuarial equivalent of the decided amount without the further
reduction referred to in subsection (2.1).

     (b)  by repealing subsection (4) and substituting the following:

          (4)  Where a person selected a pension that commenced before
2004 in the form specified in section 38(1)(c)(ii) or section 38(1)(d), as
it related to section 38(1)(c)(ii), as those provisions read at the
relevant time, the amount of the Canada Pension Plan retirement pension or
the Old Age Security benefit or both to be received or recovered under
those subsections remain subject to reduction in the same manner as the
basic pension.

     (c)  in subsection (7) by striking out "estimated" wherever it
occurs and substituting "decided amount of";

     (d)  by adding the following after subsection (8):

          (9)  Notwithstanding anything in this section, a person is not
entitled to make a choice under this section if the monthly pension
payments payable to that person under both Subdivisions A and B of a
Division of this Part, after the reduction by the decided amount of Canada
Pension Plan retirement pension or the Old Age Security benefit or both, as
the case may be, has commenced, will be less than 1/12 of 4% of the year's
maximum pensionable earnings for the calendar year in which the termination
or death occurred.

          (10)  The conditions set out in subsections (1) or (2) and (3),
as they existed prior to their repeal by Part 1 of the Public Sector
Pension Plans (Miscellaneous 2004) Amendment Regulation, continue to apply
with respect to a choice made under that subsection (1) or (2) in respect
of a pension commencing in or before 2003, but if the choice relates to a
pension commencing on or after January 1, 2004, the choice is deemed to
have been made under subsection (1) as it exists on January 1, 2004.


9   Section 84(3) is repealed.


10   Section 93 is amended

     (a)  by repealing subsection (3) and substituting the following:

          (2.1)  Section 80(2.1) applies.

          (2.2)  Section 80(2.2) applies.

     (b)  by repealing subsection (4) and substituting the following:

          (4)  Section 80(4) applies, with the reference to section 38(1)
being taken as a reference to section 49, so far as it incorporated section
38(1).

     (c)  by adding the following after subsection (8):

          (9)  Section 80(9) applies.

          (10)  Section 80(10) applies.


11   Section 97 is amended by repealing subsection (3).


12   Section 116.2 is amended

     (a)  by renumbering it as section 116.2(1);

     (b)  in subsection (1) by striking out "that came into force on
September 1, 2000" and substituting "(AR 143/2000)";

     (c)  by adding the following after subsection (1):

          (2)  To avoid doubt, the amendments contained in section 4 of
the Public Sector Pension Plans (Miscellaneous 2004) Amendment Regulation
apply, where applicable, to persons referred to in subsection (1).


13   Schedule 1 is amended by repealing Form 1 and substituting the
following:

     FORM 1
     Sections 37(3)(a) and 48

     PENSION WAIVER OF PENSION PARTNER
     AS AT PENSION COMMENCEMENT

     STATUTORY DECLARATION

CANADA                   )    IN THE MATTER OF A PENSION
FOR PROVINCE   )    PARTNER WAIVER OF BENEFITS
OF ALBERTA          )    UNDER THE LOCAL
TO WIT                   )    AUTHORITIES PENSION PLAN


     NOTE:     If this declaration is signed before pension  commencement, it
has no effect until then.  It should reflect circumstances at pension
commencement.  Therefore, if stated circumstances change between now and
pension commencement, you should notify the Minister.  The form is dealing
with the situation as at pension commencement, despite the fact that the
declaration may be signed before or after pension commencement.  It may not
be signed more than 90 days before pension commencement in any case.

I,                (Full Name of "pension partner")                , of the
(Municipal Status) of (Municipality) in (Province/Territory/State/ Country
(if other than Canada) solemnly declare as follows:

1.   As of (Date of Pension Commencement) I am  the "pension partner" (as
described below) of  (Name of Prospective Pensioner)  ("the pensioner"), a
retiring member of the Local Authorities Pension Plan ("the Plan").

2.   Being the pensioner's "pension partner" means that as of pension
commencement I meet one of the following sets of conditions:

               (a)  I am married to and not judicially or otherwise
separated from the pensioner;

               (b)  I am married to and judicially or otherwise
separated from the pensioner but wholly or substantially dependent on the
pensioner;

               (c)  there is no one who falls within paragraph (a) or
(b) above, and

                         (i)  I have lived continuously with the
pensioner for the 3 years immediately before pension commencement in a
conjugal relationship, and throughout that 3-year period I have been
represented by the pensioner in our community as being in a conjugal
relationship with the pensioner, or

                         (ii) I have lived with the pensioner in a
conjugal relationship of some permanence up to pension commencement of
which there is a child or children by birth or adoption, and throughout
that period I have been represented by the pensioner in our community as
being in a conjugal relationship with the pensioner;

               (d)  there is no one who falls within paragraph (a), (b)
or (c) above, and I am married to but separated from the pensioner and not
wholly or substantially dependent on the pensioner.

3.   I understand that if in fact I am the pensioner's pension partner at
pension commencement, the Plan requires that the pensioner take a form of
pension which, after the death of either of us, will continue to be paid to
the survivor for life in an amount that is at least 2/3 of the amount that
would have been payable to the pensioner had we both continued to live. 
This means that if the pensioner starts to receive a pension and dies
before I do, survivor payments equal to at least 2/3 of the original amount
will continue to me for my lifetime.

4.   I also understand that if I sign this waiver form and it is filed
with the Minister I will have given up my rights to the survivor benefit
described above.  I further understand that signing this waiver means that
the pensioner may choose a pension that provides me with a lower survivor
pension benefit than described above or no survivor pension benefit at all
and that the pensioner has no obligation to grant me any benefit under the
pension plan or other vehicle whatsoever.

5.   Understanding everything described above, I nevertheless waive my
rights to the minimum 2/3 joint and survivor pension required by the Plan.

6.   I have read this form and understand it.

7.   The facts stated were true as at pension commencement (if that date
has passed) or will truly reflect circumstances at pension commencement to
the best of my knowledge and belief (if that date has not yet arrived).

8.   I have read and reviewed information on all the pension options
available to the pensioner, including those that would give me a survivor
pension and the pensioner's retirement statement showing the balance in the
pensioner's account and know the amount of the benefit I am giving up.

9.   I am signing this form of my own free will and not under any form of
pressure.

10.  The pensioner is not present while I am signing this form.

11.  I realize that

               (i)  this form only gives a general description of the
legal rights I have under the Plan,

               (ii) if I wish to understand exactly what my legal
rights are, it may be necessary that I seek legal advice, and

               (iii)     the subject-matter of this waiver form may involve
complex financial decisions.

12.  I certify that I have either obtained independent legal and/or
financial advice or that I do not wish to obtain it.

To waive my rights described above, I sign this waiver form.

And I make this solemn declaration conscientiously believing it to be true
and knowing that it is of the same force and effect as if made under oath.

DECLARED before me            )
at the               of                 )        (Signature of        
in                        this               )            pension partner)    
     
day of                   , 20           )
                                           
A Commissioner for Oaths in
and for the Province/Territory
of                                    


     Part 2
     Public Service Pension Plan

14   The Public Service Pension Plan (AR 368/93) is amended by this Part.


15   Section 2(1) is amended by adding the following after clause (ss):

     (ss.2)    "vested" means, in relation to a participant, having

               (i)  accumulated at least 2 years' combined pensionable
service, or

               (iii)     attained the age of 65 years;


16   Section 11 is amended by repealing clause (c).


17   Section 33 is amended

     (a)  in subsection (2) by striking out ", or" at the end of clause
(a) and by repealing clause (b);

     (b)  by adding the following after subsection (2):

          (3)  Notwithstanding anything in this Part, a former
participant or the surviving pension partner of a deceased participant or
former participant who is entitled to select a pension or commuted value is
entitled, as an option, to be paid or to have transferred an amount equal
to the commuted value of the pension to which the former participant or
surviving pension partner is (or, in the case of a former participant to
whom sections 66 and 69 or 72 or all of those sections apply, will be)
entitled if

               (a)  the monthly payments of normal pension that would
or will be or that would have been payable to the former participant or the
deceased, as the case may be,

                         (i)  on reaching the age of 65 years, in the
case of a person who terminated or died, as the case may be, before
reaching that age, or

                         (ii) at termination or death, as the case
may be, in the case of a person who terminated or died having reached that
age,

                    do not exceed 1/12 of 4% of the year's maximum
pensionable earnings for the calendar year in which the termination or
death, as the case may be, occurred, or

               (b)  where payment or transfer of the commuted value
under Division 2 or 3, as the case may be, is allowed, the commuted value
to which that former participant or surviving pension partner is entitled
does not exceed 20% of that year's maximum pensionable earnings.

     (4)  In calculating the normal pension for the purposes of subsection
(3)(a) with reference to a person referred to in subsection (3)(a)(i), the
assumption as to reaching the age of 65 years

               (a)  is not to be taken to result in any increase in
pensionable service not actually performed, any actuarial increase on
postponement or any cost-of-living or any other adjustment, and

               (b)  in the case of a person who is entitled to a
pension under section 39 or 50, or both, is to be taken as negating the
reduction under that section or those sections.


18   Section 36(1) is amended by repealing clause (b) and substituting the
following:

     (b)  is vested, and


19   Section 39(1) is amended by repealing clause (b) and substituting the
following:

     (b)  who is vested,


20   Section 40(1) is amended by striking out "and who has accumulated at
least 2 years' combined pensionable service".


21   Section 41(1)(a) and (2)(a) are repealed and the following is
substituted:

     (a)  is vested,


22   Section 59 is amended

     (a)  in clause (a) by striking out "had at least 2 years' combined
pensionable service accumulated" and substituting "was vested";

     (b)  in clause (b) by striking out "had less than 2 years' combined
pensionable service accumulated," and substituting "was not vested,".


23   Section 60 is amended

     (a)  in subsection (1) by striking out "had at least 2 years'
combined pensionable service accumulated" and substituting "was vested";

     (b)  in subsection (2) by striking out "had less than 2 years'
combined pensionable service accumulated" and substituting "was not
vested".


24   Section 64 is amended


     (a)  in clause (a) by striking out "had at least 2 years' combined
pensionable service accumulated" and substituting "was vested";
     
     (b)  in clause (b) by striking out "had less than 2 years' combined
pensionable service accumulated," and substituting "was not vested,".


25   Section 65 is amended

     (a)  in subsection (1) by striking out "had at least 2 years'
combined pensionable service accumulated" and substituting "was vested";

     (b)  in subsection (2) by striking out "had less than 2 years'
combined pensionable service accumulated" and substituting "was not
vested".


26   Section 69 is amended by striking out "has accumulated at least 2
years' combined pensionable service" and substituting "is vested".


27   Section 70 is amended

     (a)  by renumbering it as section 70(1);

     (b)  in subsection (1)

               (i)  by striking out "has accumulated less than 2 years'
combined pensionable service" and substituting "is not vested";

               (ii) in clause (c) by striking out "73(c)" and
substituting "73(1)(c)";

     (c)  by adding the following after subsection (1):

     (2)  Notwithstanding subsection (1), if the person does not make the
choice under that subsection within 90 days after being requested by the
Minister to do so, the Minister shall pay the benefit under subsection
(1)(a).


28   Section 72 is amended by striking out "has accumulated at least 2
years' combined pensionable service" and substituting "is vested".


29   Section 73 is amended

     (a)  by renumbering it as section 73(1);

     (b)  in subsection (1)

               (i)  by striking out "has accumulated less than 2 years'
combined pensionable service" and substituting "is not vested";

               (ii) in clause (c) by striking out "70(c)" and
substituting "70(1)(c)";

     (c)  by adding the following after subsection (1):

     (2)  Section 70(2) applies.


30   Section 80 is amended

     (a)  by repealing subsections (1), (2) and (3) and substituting the
following:

Co-ordination of certain pensions with C.P.P. and O.A.S.
     80(1)  Where a person is to receive a pension commencing on or after
January 1, 2004 under section 36, 39, 41(2) or 69(d) before attaining the
age of 65 years, he may choose to increase the pension by an amount equal
to the actuarial equivalent of such amount as that person decides, which
amount so decided is in this section referred to, as applicable, as the
"decided amount" and is to be an amount not exceeding but decided by
reference to the maximum Canada Pension Plan retirement pension or the Old
Age Security benefit or both until he reaches the age of 65 years or dies
before reaching that age.

     (2)  Where a person is to receive a pension commencing on or after
January 1, 2004 under section 41(1) or 59(a)(i) before attaining the age of
65 years, he may choose to increase the pension by an amount equal to the
actuarial equivalent of such amount as that person decides, which amount so
decided is in this section referred to, as applicable, as the "decided
amount" and is to be an amount not exceeding but decided by reference to
the maximum Old Age Security benefit until he reaches the age of 65 years
or dies before reaching that age.

     (2.1)  Where a person who has chosen to increase a pension under
subsection (1) or (2) attains the age of 65 years, the increased pension,
including the added amount, shall be reduced at that time by the actuarial
equivalent of the decided amount and, for (but only for) the remainder of
that person's lifetime, the pension shall be further reduced from that time
by the difference between the decided amount and the actuarial equivalent
of the decided amount.

     (2.2)  Where a person who has chosen to increase a pension under
subsection (1) or (2) dies before attaining the age of 65 years, the
increased pension, including the added amount, shall be reduced at that
time by the actuarial equivalent of the decided amount without the further
reduction referred to in subsection (2.1).

     (b)  by repealing subsection (4) and substituting the following:

          (4)  Where a person selected a pension that commenced before
2004 in the form specified in section 38(1)(c)(ii) or section 38(1)(d), as
it related to section 38(1)(c)(ii), as that provision read at the relevant
time, the amount of the Canada Pension Plan retirement pension or the Old
Age Security benefit or both to be received or recovered under those
subsections remain subject to reduction in the same manner as the basic
pension.

     (c)  in subsection (7) by striking out "estimated" wherever it
occurs and substituting "decided amount of";

     (d)  by adding the following after subsection (8):

          (9)  Notwithstanding anything in this section, a person is not
entitled to make a choice under this section if the monthly pension
payments payable to that person under both Subdivisions A and B of a
Division of this Part, after the reduction by the decided amount of Canada
Pension Plan retirement pension or the Old Age Security benefit or both, as
the case may be, has commenced, will be less than 1/12 of 4% of the year's
maximum pensionable earnings for the calendar year in which the termination
or death occurred.

     (10)  The conditions set out in subsections (1) or (2) and (3), as
they existed prior to their repeal by Part 2 of the Public Sector Pension
Plans (Miscellaneous 2004) Amendment Regulation, continue to apply with
respect to a choice made under that subsection (1) or (2) in respect of a
pension commencing in or before 2003, but if the choice relates to a
pension commencing on or after January 1, 2004, the choice is deemed to
have been made under subsection (1) as it exists on January 1, 2004.


31   Section 84 is amended

     (a)  in subsection (2)(a)

               (i)  in subclause (i) by striking out "has accumulated
at least 2 years' combined pensionable service" and substituting "is
vested";

               (ii) in subclause (ii) by striking out "has not
accumulated at least 2 years' combined pensionable service" and
substituting "is not vested";

     (b)  by repealing subsection (3).


32   Section 93 is amended

     (a)  by repealing subsection (3) and substituting the following:

     (2.1)  Section 80(2.1) applies.

     (2.2)  Section 80(2.2) applies.

     (b)  by repealing subsection (4) and substituting the following:

          (4)  Section 80(4) applies, with the reference to section 38(1)
being taken as a reference to section 49, so far as it incorporated section
38(1).

     (c)  by adding the following after subsection (8):

          (9)  Section 80(9) applies.

          (10)  Section 80(10) applies.


33   Section 97 is amended by repealing subsection (3).


34   Section 117.1(7) is repealed.


35   Schedule 1 is amended by repealing Form 1 and substituting the
following:

     FORM 1
     Sections 37(3)(a) and 48

     PENSION WAIVER OF PENSION PARTNER
     AS AT PENSION COMMENCEMENT

     STATUTORY DECLARATION

CANADA                   )    IN THE MATTER OF A PENSION
FOR PROVINCE   )    PARTNER WAIVER OF BENEFITS
OF ALBERTA          )    UNDER THE PUBLIC SERVICE
TO WIT                   )    PENSION PLAN


     NOTE:     If this declaration is signed before pension  commencement, it
has no effect until then.  It should reflect circumstances at pension
commencement.  Therefore, if stated circumstances change between now and
pension commencement, you should notify the Minister.  The form is dealing
with the situation as at pension commencement, despite the fact that the
declaration may be signed before or after pension commencement.  It may not
be signed more than 90 days before pension commencement in any case.

I,                (Full Name of "pension partner")                , of the
(Municipal Status) of (Municipality) in (Province/Territory/State/ Country
(if other than Canada) solemnly declare as follows:

1.   As of (Date of Pension Commencement) I am  the "pension partner" (as
described below) of  (Name of Prospective Pensioner)  ("the pensioner"), a
retiring member of the Public Service Pension Plan ("the Plan").

2.   Being the pensioner's "pension partner" means that as of pension
commencement I meet one of the following sets of conditions:

               (a)  I am married to and not judicially or otherwise
separated from the pensioner;

               (b)  I am married to and judicially or otherwise
separated from the pensioner but wholly or substantially dependent on the
pensioner;

               (c)  there is no one who falls within paragraph (a) or
(b) above, and

                         (i)  I have lived continuously with the
pensioner for the 3 years immediately before pension commencement in a
conjugal relationship, and throughout that 3-year period I have been
represented by the pensioner in our community as being in a conjugal
relationship with the pensioner, or

                         (ii) I have lived with the pensioner in a
conjugal relationship of some permanence up to pension commencement of
which there is a child or children by birth or adoption, and throughout
that period I have been represented by the pensioner in our community as
being in a conjugal relationship with the pensioner;

               (d)  there is no one who falls within paragraph (a), (b)
or (c) above, and I am married to but separated from the pensioner and not
wholly or substantially dependent on the pensioner.

3.   I understand that if in fact I am the pensioner's pension partner at
pension commencement, the Plan requires that the pensioner take a form of
pension which, after the death of either of us, will continue to be paid to
the survivor for life in an amount that is at least 2/3 of the amount that
would have been payable to the pensioner had we both continued to live. 
This means that if the pensioner starts to receive a pension and dies
before I do, survivor payments equal to at least 2/3 of the original amount
will continue to me for my lifetime.

4.   I also understand that if I sign this waiver form and it is filed
with the Minister I will have given up my rights to the survivor benefit
described above.  I further understand that signing this waiver means that
the pensioner may choose a pension that provides me with a lower survivor
pension benefit than described above or no survivor pension benefit at all
and that the pensioner has no obligation to grant me any benefit under the
pension plan or other vehicle whatsoever.

5.   Understanding everything described above, I nevertheless waive my
rights to the minimum 2/3 joint and survivor pension required by the Plan.

6.   I have read this form and understand it.

7.   The facts stated were true as at pension commencement (if that date
has passed) or will truly reflect circumstances at pension commencement to
the best of my knowledge and belief (if that date has not yet arrived).

8.   I have read and reviewed information on all the pension options
available to the pensioner, including those that would give me a survivor
pension and the pensioner's retirement statement showing the balance in the
pensioner's account and know the amount of the benefit I am giving up.

9.   I am signing this form of my own free will and not under any form of
pressure.

10.  The pensioner is not present while I am signing this form.

11.  I realize that

               (i)  this form only gives a general description of the
legal rights I have under the Plan,

               (ii) if I wish to understand exactly what my legal
rights are, it may be necessary that I seek legal advice, and

               (iii)     the subject-matter of this waiver form may involve
complex financial decisions.

12.  I certify that I have either obtained independent legal and/or
financial advice or that I do not wish to obtain it.

To waive my rights described above, I sign this waiver form.

And I make this solemn declaration conscientiously believing it to be true
and knowing that it is of the same force and effect as if made under oath.

DECLARED before me            )
at the               of                 )        (Signature of        
in                        this               )            pension partner)    
     
day of                   , 20           )


                                           
A Commissioner for Oaths in
and for the Province/Territory
of                                    


     Part 3
     Special Forces Pension Plan

36   The Special Forces Pension Plan (AR 369/93) is amended by this Part.


37   Section 2(1) is amended by adding the following after clause (ss):

     (ss.2)    "vested" means, in relation to a participant, having

               (i)  accumulated at least 5 years' pensionable service,
or

               (iii)     attained the age of 65 years;


38   Section 11 is amended by repealing clause (c).


39   Section 36(1) is amended by striking out everything to the end of
clause (b) and substituting the following:

Normal pension based on age or service
     36(1)  A person who terminates and either

               (a)  is vested and has attained the age of 55 years, or

               (b)  has accumulated at least 25 years' pensionable
service,


40   Section 40 is amended by striking out "and who has accumulated at
least 5 years' pensionable service".


41   Section 41(1)(a) and (2)(a) are repealed and the following is
substituted:

     (a)  is vested,


42   Section 59(1) is amended

     (a)  by striking out "had at least 5 years' pensionable service
accumulated" and substituting "was vested";


     (b)  in clause (b) by striking out "with less than 5 years'
pensionable service accumulated" and substituting "not being vested".


43   Section 60(1)(a) is amended by striking out "had at least 5 years'
pensionable service accumulated or died while an employee with less than
that" and substituting "was vested or died while an employee but not
vested".


44   Section 64 is amended

     (a)  in clause (a) by striking out "had at least 5 years'
pensionable service accumulated" and substituting "was vested";

     (b)  in clause (b) by striking out "had less than 5 years'
pensionable service accumulated" and substituting "was not vested".


45   Section 65 is amended

     (a)  in subsection (1) by striking out "had at least 5 years'
pensionable service accumulated" and substituting "was vested";

     (b)  in subsection (2) by striking out "had less than 5 years'
pensionable service accumulated" and substituting "was not vested".


46   Section 69 is amended by striking out "has accumulated at least 5
years' pensionable service" and substituting "is vested".


47   Section 70 is amended by striking out "has accumulated less than 5
years' pensionable service" and substituting "is not vested".


48   Section 72 is amended by striking out "has accumulated at least 5
years' pensionable service" and substituting "is vested".


49   Section 73 is amended by striking out "has accumulated less than 5
years' pensionable service" and substituting "is not vested".


50   Section 80 is amended

     (a)  in subsections (1) and (2) by striking out from "or would" to
the end and substituting "the age of 65 years or dies before reaching that
age";

     (b)  by adding the following after subsection (2):

     (2.1)  Where a person who has chosen to increase a pension under
subsection (1) or (2) attains the age of 65 years, the increased pension,
including the added amount, shall be reduced at that time by the actuarial
equivalent of the previously estimated Canada Pension Plan retirement
pension or Old Age Security benefit, or both, as the case may be, and, for
(but only for) the remainder of that person's lifetime, the pension shall
be further reduced from that time by the difference between the previously
estimated amount and the actuarial equivalent of the previously estimated
amount.

     (2.2)  Where a person who has chosen to increase a pension under
subsection (1) or (2) dies before attaining the age of 65 years, the
increased pension, including the added amount, shall be reduced at that
time by the actuarial equivalent of the previously estimated Canada Pension
Plan retirement pension or Old Age Security benefit, or both, as the case
may be, without the further reduction referred to in subsection (2.1).

     (c)  by repealing subsections (3), (5) and (6);

     (d)  by adding the following after subsection (8):

          (9)  Notwithstanding anything in this section, a person is not
entitled to make a choice under this section if the monthly pension
payments payable to that person under both Subdivisions A and B of a
Division of this Part, after the reduction by the previously estimated
amount of Canada Pension Plan retirement pension or the Old Age Security
benefit or both, as the case may be, has commenced, will be less than 1/12
of 4% of the year's maximum pensionable earnings for the calendar year in
which the termination or death occurred.

     (10)  The conditions set out in subsections (1) or (2) and (3) or
(6), as they existed prior to their repeal by Part 3 of the Public Sector
Pension Plans (Miscellaneous 2004) Amendment Regulation, continue to apply
with respect to a choice or selection made thereunder in respect of a
pension commencing in or before 2003, but if a choice under subsection (1)
or (2) relates to a pension commencing on or after January 1, 2004, the
choice is deemed to have been made under subsection (1) as it exists on
January 1, 2004.


51   Section 84(2)(c) is repealed.


52   Section 93 is amended

     (a)  by repealing subsections (3), (5) and (6) and substituting the
following:

     (2.1)  Section 80(2.1) applies.

     (2.2)  Section 80(2.2) applies.

     (b)  by adding the following after subsection (8):

          (9)  Section 80(9) applies.

          (10)  Section 80(10) applies.


53   Section 97(2)(b) is amended by striking out "(c),".


54   Schedule 1 is amended by repealing Form 1 and substituting the
following:

     FORM 1
     Sections 37(3)(a) and 48

     PENSION WAIVER OF PENSION PARTNER
     AS AT PENSION COMMENCEMENT

     STATUTORY DECLARATION

CANADA                   )    IN THE MATTER OF A PENSION
FOR PROVINCE   )    PARTNER WAIVER OF BENEFITS
OF ALBERTA          )    UNDER THE SPECIAL
TO WIT                   )    FORCES PENSION PLAN


     NOTE:     If this declaration is signed before pension  commencement, it
has no effect until then.  It should reflect circumstances at pension
commencement.  Therefore, if stated circumstances change between now and
pension commencement, you should notify the Minister.  The form is dealing
with the situation as at pension commencement, despite the fact that the
declaration may be signed before or after pension commencement.  It may not
be signed more than 90 days before pension commencement in any case.

I,                (Full Name of "pension partner")                , of the
(Municipal Status) of (Municipality) in (Province/Territory/State/ Country
(if other than Canada) solemnly declare as follows:

1.   As of (Date of Pension Commencement) I am  the "pension partner" (as
described below) of  (Name of Prospective Pensioner)  ("the pensioner"), a
retiring member of the Special Forces Pension Plan ("the Plan").

2.   Being the pensioner's "pension partner" means that as of pension
commencement I meet one of the following sets of conditions:

               (a)  I am married to and not judicially or otherwise
separated from the pensioner;

               (b)  I am married to and judicially or otherwise
separated from the pensioner but wholly or substantially dependent on the
pensioner;

               (c)  there is no one who falls within paragraph (a) or
(b) above, and

                         (i)  I have lived continuously with the
pensioner for the 3 years immediately before pension commencement in a
conjugal relationship, and throughout that 3-year period I have been
represented by the pensioner in our community as being in a conjugal
relationship with the pensioner, or

                         (ii) I have lived with the pensioner in a
conjugal relationship of some permanence up to pension commencement of
which there is a child or children by birth or adoption, and throughout
that period I have been represented by the pensioner in our community as
being in a conjugal relationship with the pensioner;

               (d)  there is no one who falls within paragraph (a), (b)
or (c) above, and I am married to but separated from the pensioner and not
wholly or substantially dependent on the pensioner.

3.   I understand that if in fact I am the pensioner's pension partner at
pension commencement, the Plan requires that the pensioner take a form of
pension which, after the death of either of us, will continue to be paid to
the survivor for life in an amount that is at least 2/3 of the amount that
would have been payable to the pensioner had we both continued to live. 
This means that if the pensioner starts to receive a pension and dies
before I do, survivor payments equal to at least 2/3 of the original amount
will continue to me for my lifetime.

4.   I also understand that if I sign this waiver form and it is filed
with the Minister I will have given up my rights to the survivor benefit
described above.  I further understand that signing this waiver means that
the pensioner may choose a pension that provides me with a lower survivor
pension benefit than described above or no survivor pension benefit at all
and that the pensioner has no obligation to grant me any benefit under the
pension plan or other vehicle whatsoever.

5.   Understanding everything described above, I nevertheless waive my
rights to the minimum 2/3 joint and survivor pension required by the Plan.

6.   I have read this form and understand it.

7.   The facts stated were true as at pension commencement (if that date
has passed) or will truly reflect circumstances at pension commencement to
the best of my knowledge and belief (if that date has not yet arrived).

8.   I have read and reviewed information on all the pension options
available to the pensioner, including those that would give me a survivor
pension and the pensioner's retirement statement showing the balance in the
pensioner's account and know the amount of the benefit I am giving up.

9.   I am signing this form of my own free will and not under any form of
pressure.

10.  The pensioner is not present while I am signing this form.


11.  I realize that

               (i)  this form only gives a general description of the
legal rights I have under the Plan,

               (ii) if I wish to understand exactly what my legal
rights are, it may be necessary that I seek legal advice, and

               (iii)     the subject-matter of this waiver form may involve
complex financial decisions.

12.  I certify that I have either obtained independent legal and/or
financial advice or that I do not wish to obtain it.

To waive my rights described above, I sign this waiver form.

And I make this solemn declaration conscientiously believing it to be true
and knowing that it is of the same force and effect as if made under oath.

DECLARED before me            )
at the               of                 )        (Signature of        
in                        this               )            pension partner)    
     
day of                   , 20           )

                                           
A Commissioner for Oaths in
and for the Province/Territory
of                                    


     Part 4
     Management Employees Pension Plan

55   The Management Employees Pension Plan (AR 367/93) is amended by this
Part.


56   Section 2(1) is amended by adding the following after clause (ss):

     (ss.2)    "vested" means, in relation to a participant, having

               (i)  accumulated at least 5 years' combined pensionable
service, or

               (iii)     attained the age of 65 years;


57   Section 11 is amended by repealing clause (c).


58   Section 36(1) is amended by striking out "and has attained the age of
55 years with at least 5 years' combined pensionable service accumulated"
and substituting ", is vested and has attained the age of 55 years".


59   Section 40 is amended by striking out "and who has accumulated at
least 5 years' combined pensionable service".


60   Section 41(1)(a) and (2)(a) are repealed and the following is
substituted:

     (a)  is vested,


61   Section 47(1) is amended by repealing clause (b) and substituting the
following:

     (b)  is vested, and


62   Section 59 is amended

     (a)  by striking out "had at least 5 years' combined pensionable
service accumulated" and substituting "was vested";

     (b)  in clause (b) by striking out "with less than 5 years' combined
pensionable service accumulated" and substituting "not being vested".


63   Section 60(a) is amended by striking out "had at least 5 years'
combined pensionable service accumulated or died while an employee with
less than that" and substituting "was vested or died while an employee but
not vested".


64   Section 64 is amended

     (a)  in clause (a) by striking out "had at least 5 years' combined
pensionable service accumulated" and substituting "was vested";

     (b)  in clause (b) by striking out "had less than 5 years' combined
pensionable service accumulated" and substituting "was not vested".


65   Section 65 is amended

     (a)  in subsection (1) by striking out "had at least 5 years'
combined pensionable service accumulated" and substituting "was vested";

     (b)  in subsection (2) by striking out "had less than 5 years'
combined pensionable service accumulated" and substituting "was not
vested".


66   Section 69 is amended by striking out "has accumulated at least 5
years' combined pensionable service" and substituting "is vested".


67   Section 70 is amended by striking out "has accumulated less than 5
years' combined pensionable service" and substituting "is not vested".


68   Section 72 is amended by striking out "has accumulated at least 5
years' combined pensionable service" and substituting "is vested".


69   Section 73 is amended by striking out "has accumulated less than 5
years' combined pensionable service" and substituting "is not vested".


70   Section 80 is amended

     (a)  by repealing subsections (1) to (6) and substituting the
following:

Co-ordination of certain pensions with C.P.P. and O.A.S.
     80(1)  Where a person is to receive a pension commencing on or after
January 1, 2004 under section 36, 41(2) or 69(d) before attaining the age
of 65 years, he may choose to increase the pension by an amount equal to
the actuarial equivalent of such amount as that person decides, which
amount so decided is in this section referred to, as applicable, as the
"decided amount" and is to be an amount not exceeding but decided by
reference to the maximum Canada Pension Plan retirement pension or the Old
Age Security benefit or both until he reaches the age of 65 years or dies
before reaching that age.

     (2)  Where a person is to receive a pension commencing on or after
January 1, 2004 under section 41(1) or 59(a)(i) before attaining the age of
65 years, he may choose to increase the pension by an amount equal to the
actuarial equivalent of such amount as that person decides, which amount so
decided is in this section referred to, as applicable, as the "decided
amount" and is to be an amount not exceeding but decided by reference to
the maximum Old Age Security benefit until he reaches the age of 65 years
or dies before reaching that age.

     (2.1)  Where a person who has chosen to increase a pension under
subsection (1) or (2) attains the age of 65 years, the increased pension,
including the added amount, shall be reduced at that time by the actuarial
equivalent of the decided amount and, for (but only for) the remainder of
that person's lifetime, the pension shall be further reduced from that time
by the difference between the decided amount and the actuarial equivalent
of the decided amount.

     (2.2)  Where a person who has chosen to increase a pension under
subsection (1) or (2) dies before attaining the age of 65 years, the
increased pension, including the added amount, shall be reduced at that
time by the actuarial equivalent of the decided amount without the further
reduction referred to in subsection (2.1).

     (b)  in subsection (7) by striking out "estimated" wherever it
occurs and substituting "decided amount of";

     (c)  by adding the following after subsection (8):

     (9)  Notwithstanding anything in this section, a person is not
entitled to make a choice under this section if the monthly pension
payments payable to that person under both Subdivisions A and B of a
Division of this Part, after the reduction by the decided amount of Canada
Pension Plan retirement pension or the Old Age Security benefit or both, as
the case may be, has commenced, will be less than 1/12 of 4% of the year's
maximum pensionable earnings for the calendar year in which the termination
or death occurred.

     (10)  The conditions set out in subsections (1) or (2) and (3) or
(6), as they existed prior to their repeal by Part 4 of the Public Sector
Pension Plans (Miscellaneous 2004) Amendment Regulation, continue to apply
with respect to a choice or selection made thereunder in respect of a
pension commencing in or before 2003, but if a choice under subsection (1)
or (2) relates to a pension commencing on or after January 1, 2004, the
choice is deemed to have been made under subsection (1) as it exists on
January 1, 2004.


71   Section 84(3) is repealed.


72   Section 93 is amended

     (a)  by repealing subsections (3), (5) and (6) and substituting the
following:

     (2.1)  Section 80(2.1) applies.

     (2.2)  Section 80(2.2) applies.

     (b)  by adding the following after subsection (8):

          (9)  Section 80(9) applies.

          (10)  Section 80(10) applies.


73   Section 97(3) is repealed.


74   Schedule 1 is amended by repealing Form 1 and substituting the
following:

     FORM 1
     Sections 37(3)(a) and 48

     PENSION WAIVER OF PENSION PARTNER
     AS AT PENSION COMMENCEMENT

     STATUTORY DECLARATION

CANADA                   )    IN THE MATTER OF A PENSION
FOR PROVINCE   )    PARTNER WAIVER OF BENEFITS
OF ALBERTA          )    UNDER THE MANAGEMENT
TO WIT                   )    EMPLOYEES PENSION PLAN


     NOTE:     If this declaration is signed before pension  commencement, it
has no effect until then.  It should reflect circumstances at pension
commencement.  Therefore, if stated circumstances change between now and
pension commencement, you should notify the Minister.  The form is dealing
with the situation as at pension commencement, despite the fact that the
declaration may be signed before or after pension commencement.  It may not
be signed more than 90 days before pension commencement in any case.

I,                (Full Name of "pension partner")                , of the
(Municipal Status) of (Municipality) in (Province/Territory/State/ Country
(if other than Canada) solemnly declare as follows:

1.   As of (Date of Pension Commencement) I am  the "pension partner" (as
described below) of  (Name of Prospective Pensioner)  ("the pensioner"), a
retiring member of the Management Employees Pension Plan ("the Plan").

2.   Being the pensioner's "pension partner" means that as of pension
commencement I meet one of the following sets of conditions:

               (a)  I am married to and not judicially or otherwise
separated from the pensioner;

               (b)  I am married to and judicially or otherwise
separated from the pensioner but wholly or substantially dependent on the
pensioner;

               (c)  there is no one who falls within paragraph (a) or
(b) above, and

                         (i)  I have lived continuously with the
pensioner for the 3 years immediately before pension commencement in a
conjugal relationship, and throughout that 3-year period I have been
represented by the pensioner in our community as being in a conjugal
relationship with the pensioner, or

                         (ii) I have lived with the pensioner in a
conjugal relationship of some permanence up to pension commencement of
which there is a child or children by birth or adoption, and throughout
that period I have been represented by the pensioner in our community as
being in a conjugal relationship with the pensioner;

               (d)  there is no one who falls within paragraph (a), (b)
or (c) above, and I am married to but separated from the pensioner and not
wholly or substantially dependent on the pensioner.

3.   I understand that if in fact I am the pensioner's pension partner at
pension commencement, the Plan requires that the pensioner take a form of
pension which, after the death of either of us, will continue to be paid to
the survivor for life in an amount that is at least 2/3 of the amount that
would have been payable to the pensioner had we both continued to live. 
This means that if the pensioner starts to receive a pension and dies
before I do, survivor payments equal to at least 2/3 of the original amount
will continue to me for my lifetime.

4.   I also understand that if I sign this waiver form and it is filed
with the Minister I will have given up my rights to the survivor benefit
described above.  I further understand that signing this waiver means that
the pensioner may choose a pension that provides me with a lower survivor
pension benefit than described above or no survivor pension benefit at all
and that the pensioner has no obligation to grant me any benefit under the
pension plan or other vehicle whatsoever.

5.   Understanding everything described above, I nevertheless waive my
rights to the minimum 2/3 joint and survivor pension required by the Plan.

6.   I have read this form and understand it.

7.   The facts stated were true as at pension commencement (if that date
has passed) or will truly reflect circumstances at pension commencement to
the best of my knowledge and belief (if that date has not yet arrived).

8.   I have read and reviewed information on all the pension options
available to the pensioner, including those that would give me a survivor
pension and the pensioner's retirement statement showing the balance in the
pensioner's account and know the amount of the benefit I am giving up.

9.   I am signing this form of my own free will and not under any form of
pressure.

10.  The pensioner is not present while I am signing this form.

11.  I realize that

               (i)  this form only gives a general description of the
legal rights I have under the Plan,

               (ii) if I wish to understand exactly what my legal
rights are, it may be necessary that I seek legal advice, and

               (iii)     the subject-matter of this waiver form may involve
complex financial decisions.

12.  I certify that I have either obtained independent legal and/or
financial advice or that I do not wish to obtain it.

To waive my rights described above, I sign this waiver form.

And I make this solemn declaration conscientiously believing it to be true
and knowing that it is of the same force and effect as if made under oath.

DECLARED before me            )
at the               of                 )        (Signature of        
in                        this               )            pension partner)    
     
day of                   , 20                )

                                           
A Commissioner for Oaths in
and for the Province/Territory
of                                    


     Part 5
     Commencement

75   This Regulation comes into force on January 1, 2004.